Suchergebnisse - "Kramer, Hester"

PubPharm (10)

1

Clinical Bridging Studies and Modeling Approach for Implementation of a Patient Centric Sampling Technique in Padsevonil Clinical Development

enthalten in: The AAPS journal | 2023

von Kramer, H. | Bicer, C. | Otoul, C. | +6

2

Clinical Bridging Studies and Modeling Approach for Implementation of a Patient Centric Sampling Technique in Padsevonil Clinical Development

enthalten in: The AAPS Journal | 2023

von Kramer, H. | Bicer, C. | Otoul, C. | +6

3

Oral follicle-stimulating hormone agonist tested in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function

enthalten in: Fertility and sterility | 2016

von Gerrits, M. | Kramer, H. | el Galta, R. | +6

4

Oral follicle-stimulating hormone agonist tested in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function

enthalten in: Fertility and sterility | 2016

von Stoch, S. | van Beerendonk, G. | Galta, R. | +6

5

Oral follicle-stimulating hormone agonist tested in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function

enthalten in: Fertility and sterility | 2016

von Gerrits, M. | Kramer, H. | Galta, R. | +6

6

First evidence of ovulation induced by oral LH agonists in healthy female volunteers of reproductive age

enthalten in: The Journal of clinical endocrinology and metabolism | 2013

von Gerrits, M. | Mannaerts, B. | Kramer, H. | +2

7

First Evidence of Ovulation Induced by Oral LH Agonists in Healthy Female Volunteers of Reproductive Age

enthalten in: The journal of clinical endocrinology & metabolism | 2013

von Gerrits, M. | Mannaerts, B. | Kramer, H. | +2

8

The use of toxicokinetic data in preclinical safety assessment : a toxicologic pathologist perspective

enthalten in: Toxicologic pathology | 2007

von Ploemen, J. | Kramer, H. | Krajnc, E. | +1

9

The Use of Toxicokinetic Data in Preclinical Safety Assessment: A Toxicologic Pathologist Perspective

enthalten in: Toxicologic pathology | 2007

von Ploemen, J. | Kramer, H. | Krajnc, E. | +1

10

A No-Observed-Adverse-Effect Level of 1000 mg-kg in a 28-Day Repeated-Dose Study as a Limit Value for Acute Toxicity Testing

enthalten in: International journal of toxicology | 1998

von Pieters, M. | Kramer, H. | Slob, W.

1
[1]